
|Articles|November 30, 2007
New program promotes continuous care for transplant patients
Apotex Corp. and Centric Health Resources team up to help liver transplant patients obtain seamless care
Advertisement
Apotex Corp., maker of HepaGamB, and specialty pharmacy company Centric Health Resources have launched a program to help liver transplant patients transition from hospital to home. The HepaGamB Aftercare Access Program enables patients to receive the hepatitis B immune globulin intravenous (human) at home along with educational information, nursing services, help with obtaining reimbursement, and on-call support. More information is available at 1-(866) 588-6932.
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5







































